| 05/22/2026 5:25 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 5:22 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 3:40 PM | Roivant Sciences (1635088) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/20/2026 6:14 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 6:17 AM | Roivant Sciences (1635088) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 05/12/2026 12:19 PM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 05/06/2026 8:07 PM | Ramaswamy Vivek (1635075) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 04/22/2026 5:26 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 5:26 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 5:27 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ROIV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/21/2026 5:32 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 5:34 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 5:27 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 3:17 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/16/2026 4:24 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 04/16/2026 3:33 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/10/2026 5:00 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:07 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 6:14 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 6:00 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 6:19 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 6:20 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 8:01 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:14 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/24/2026 6:07 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 6:08 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 7:44 AM | Roivant Sciences (1635088) Filer | Form 8-K/A | |
| 03/19/2026 5:36 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:23 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:17 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 3:04 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 03/03/2026 6:13 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/24/2026 5:43 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 5:43 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 7:40 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 3:24 PM | Roivant Sciences (1635088) Subject Torti Frank (1647805) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 4:57 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 8:00 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 8:02 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up.
One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis |
| 02/13/2026 7:45 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 2:32 PM | Ramaswamy Vivek (1635075) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 02/11/2026 4:53 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 10:50 AM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 02/06/2026 6:31 AM | Roivant Sciences (1635088) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 02/06/2026 6:12 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 12:36 PM | FMR LLC (315066) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 01/22/2026 8:00 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:00 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:04 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/31/2025 8:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 3:30 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 8:00 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 8:00 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:31 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 8:36 AM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 8:05 AM | Roivant Sciences (1635088) Subject Torti Frank (1647805) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/23/2025 8:00 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:19 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/23/2025 3:04 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/19/2025 8:04 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 6:52 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 6:54 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 6:41 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:00 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 4:09 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 8:34 PM | Ramaswamy Vivek (1635075) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 4:13 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 12/15/2025 3:36 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 4:20 PM | Immunovant, Inc. (1764013) Subject Roivant Sciences (1635088) Filed by | Form SCHEDULE 13D/A | |
| 12/12/2025 4:17 PM | Immunovant, Inc. (1764013) Issuer Roivant Sciences (1635088) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 6:46 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/09/2025 3:49 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/24/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 8:02 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 7:22 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 7:24 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 7:15 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 4:52 PM | Ramaswamy Vivek (1635075) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 6:25 AM | Roivant Sciences (1635088) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/10/2025 6:21 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/07/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/07/2025 2:15 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/22/2025 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 8:01 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 8:01 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
| 10/17/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 3:37 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/15/2025 3:23 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/14/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2025 7:51 AM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/08/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/08/2025 3:15 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/07/2025 3:34 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/06/2025 3:46 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |